Navigation Links
Bradmer announces 2008 third quarter operational and financial results
Date:11/10/2008

TSX: BMR

TORONTO, Nov. 10 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a clinical oncology company specializing in the development and commercialization of cancer therapies, today announced its 2008 third quarter operational and financial results.

Operational Highlights

During the three months ended September 30, 2008 and the period subsequent to this date, the Company achieved the following milestones related to its operations and its lead drug, Neuradiab(TM), which is being studied in the Phase III GLASS-ART(TM) Trial:

- Maintained budgetary control and reduced quarterly spending;

- Signed clinical study contracts with nine of the initial 16 sites

under active consideration and activated an initial cohort of five

sites, while advancing a pipeline of additional sites in the US

through the contractual, training and regulatory process;

- Initiated dialog with Health Canada for study expansion into key

Canadian sites with the support of the Canadian Brain Cancer

consortium;

- Enrolled the first group of patients in the GLASS-ART Trial and

successfully dosed patients with Neuradiab at multiple sites;

- Announced new data from the most recent Phase II trial indicating that

the mean time to progression free survival was 77 weeks, which

compares favorably with other published results in newly diagnosed

GBM;

- Evaluated a series of technical steps that may allow a two week

extension of the shelf life of Neuradiab beyond the current six-day

specification; and

- Appointed Dr. Donald Kufe, Professor of Medicine, Harvard Medical

School and Director, Experimental Therapeutics Program, Dana-

Farber/Harvard Cancer Center and Charles James Lilly, CA, a senior

partner with a public accounting firm, to the Board of Directors of

the Company.

"The treat
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Bradmer to present at Rodman & Renshaw Healthcare Conference
2. Bradmer receives FDA approval to proceed with Phase III clinical trial
3. Bradmer announces 2008 first quarter operational and financial results
4. Bradmer announces new additions to management team
5. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
6. Notice of Bradmer Pharmaceuticals Conference Call
7. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
8. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
9. Bradmer announces additions to Scientific Advisory Board
10. Bradmer Medical Isotope Supply For Phase III Trial Secure
11. Bradmer to present at Rodman & Renshaw Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 19, 2014 B. E. Smith, ... healthcare providers, has been retained to lead a national ... Medical Center in Estes Park, Colo. The top executive ... has recently placed more than 900 healthcare executives into ... a 25-bed, not-for-profit critical access hospital and level IV ...
(Date:12/19/2014)... Hands On Mobile Spa, has announced they ... On Wheels has been transformed into a utopia for the ... seems to disappear. The Virtual Tour showcases the beauty of ... corporate events and more. , The Virtual Tour shows viewers ... is actually an overhauled Winnebago. Marla Kaplan-Pelle, Director states " ...
(Date:12/19/2014)... Slone Partners , a national recruitment firm ... and laboratory testing industries, has promoted Leslie Loveless ... announcement comes after a year of expansion by ... Boston and several new additions to the team. ... experience," said Adam Slone, Chief Executive Officer. “Diagnostics ...
(Date:12/19/2014)... 2014 The Hermitage Club at ... Southern Vermont’s Deerfield Valley, announced today that it has ... rock songs. , Three time Grammy Award Winner ... concert followed by a trail naming ceremony. Hermitage Club ... include: “I’m Alright” the theme song for the movie ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, 2014 (HealthDay ... high levels of air pollution late in pregnancy may have ... Researchers found that of nearly 1,800 U.S. women who ... most air pollution during pregnancy were twice as likely to ... the third trimester, specifically, showed the strongest correlation to autism ...
Breaking Medicine News(10 mins):Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3
... WASHINGTON, Feb. 1 The American Public,Health Association (APHA) ... of Congress voted on legislation that is,important to public ... of individual votes,and selecting key public health votes during ... In the Senate, 46 out of 100 senators voted ...
... the vital role wetlands play in society, they remain among ... and positive effects of healthy wetlands for humans, the theme ... 2 February, is Healthy Wetlands, Healthy People. , According to ... claims the lives of more than 3 million people every ...
... Clinton,Campaign today announced the endorsement of the American ... the nation,s 2.9 million,registered nurses., "Too many ... and this,country deserves a president that will make ... M. Patton, MSN, RN, CNOR. "Senator,Clinton has shown ...
... 1 The Beaumont Technology,Usability Center will begin ... Food and,Drug Administration,s study on tubing and catheter ... released a Sentinel Event Alert on the,potential dangers ... and one instance of permanent loss of function ...
... Corporation (Nasdaq: OSCI ) will release financial ... December 31, 2007 on,Wednesday, February 6, 2008 prior ... conference call will be held at 8:30 a.m. ... other members of Oscient,s,management team. The Company announced ...
... of Acne ... Treatment, ... MD and co-investigators Mikiko,Enokibori, MD, and Vic Narurkar, MD, conducted a ... of acne,ranging from mild and moderate inflammatory acne to severe nodular ...
Cached Medicine News:Health News:APHA Scores Members of Congress on Public Health Voting Record 2Health News:Connection between health of wetlands and humans in focus 2Health News:Connection between health of wetlands and humans in focus 3Health News:The American Nurses Association Endorses Senator Hillary Rodham Clinton (D-NY) 2Health News:FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project 2Health News:Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results 2Health News:New Study Shows Isolaz Can Reduce Acne Up to 90 Percent 2Health News:New Study Shows Isolaz Can Reduce Acne Up to 90 Percent 3
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... "Electrocardiogram (ECG) Devices - Global Trends, Estimates and ... http://photos.prnewswire.com/prnh/20130307/600769 Global Electrocardiogram ... by 2016. The North America ... share while Europe claims approximately ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition of the ...  report to their offering. Global Guidewires sector is ... North America accounts for nearly 35% ... claims approximately 25% (2018). Asia-Pacific ...
(Date:12/15/2014)... YORK and HERZLIYA PITUACH, Israel ... "Company") (NASDAQ: IMNP ) announced today that its ... the Board succeeding Dr. Daniel Teper who continues ... a member of Immune,s Board of Directors since 2013. ... "I am delighted to represent the interest of shareholders and ...
Breaking Medicine Technology:Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... Spica Splint provides effective long-term stabilization ... fit. Adjustable radial and palmar stays ... Gamekeper's thumb, de Quervain's, scaphoid and ... straps.,FormFit™ Splints offer superior fit and ...
Qualcare™ Thumb Spica...
... QuickCast® Cast-like splints Slip ... dryer, and QuickCast conforms to ... cools. Reheat to adjust and ... coated with a temperature-sensitive polymer ...
Medicine Products: